Unlock Market Mastery: Tickeron's Top Robot Beats SP500 3 Weeks in a Row!
In these tumultuous times, where the S&P 500 has seen its fair share of turbulence for the third consecutive week, it's becoming increasingly clear that navigating the markets demands more than just intuition. That's why we're thrilled to introduce Tickeron's top-performing robot of the week – a powerhouse designed to outperform the S&P 500 even in the face of adversity.
Our cutting-edge robot has been on a winning streak, consistently beating the S&P 500 for three weeks straight, and it's ready to help you secure profits even when the market takes a dip. This is the solution you've been waiting for in this period of market uncertainty and heightened volatility.
Swing Trader, Popular stocks ($1.5K per position): Mixed Strategy (TA&FA)
Click to view full description and closed trades for free!
What sets Tickeron's robot apart is its unmatched complexity and formidable mathematical prowess. It's tailored for traders who aspire to match the success of seasoned hedge fund professionals, offering a potent combination of two proven strategies and advanced algorithms that will revolutionize your trading experience.
Long Position Strategy: Our first strategy is meticulously designed for long positions, with a keen eye on strategically identifying the perfect moments to exit stocks during sideways movements. This precision ensures you maintain an optimal profit-to-risk ratio, allowing you to capitalize on emerging trends right from their inception. With this strategy, you can confidently ride the market waves.
Short Position Strategy: For short positions, our robot excels at pinpointing reversal points in uptrends. This is achieved through a complex set of algorithms that scrutinize data on stock volatility and price dynamics. Armed with this knowledge, you can seize opportunities when market trends take a turn, turning market reversals into profitable ventures.
Don't let market uncertainty hold you back any longer. With Tickeron's cutting-edge robot, you'll have the power of sophisticated strategies and advanced algorithms at your fingertips. Trade confidently, track numerous trades simultaneously, and secure your path to success in even the most challenging market conditions.
Here are the latest trades:
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ATOS's RSI Indicator recovers from overbought zone
The 10-day RSI Indicator for ATOS moved out of overbought territory on August 18, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 instances where the indicator moved out of the overbought zone. In of the 30 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 50 cases where ATOS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ATOS broke above its upper Bollinger Band on August 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on August 12, 2026. You may want to consider a long position or call options on ATOS as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
ATOS moved above its 50-day moving average on August 13, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ATOS crossed bullishly above the 50-day moving average on August 18, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ATOS advanced for three days, in of 232 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 143 cases where ATOS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.945) is normal, around the industry mean (20.145). P/E Ratio (0.000) is within average values for comparable stocks, (22.992). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.861). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (444.692).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ATOS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of products for breast cancer
Industry Biotechnology
Advertisement